amifostine anhydrous has been researched along with Adrenal Cancer in 1 studies
Amifostine: A phosphorothioate proposed as a radiation-protective agent. It causes splenic vasodilation and may block autonomic ganglia.
amifostine : An organic thiophosphate that is the S-phospho derivative of 2-[(3-aminopropyl)amino]ethanethiol. A prodrug for the free thiol, WR-1065, which is used as a cytoprotectant in cancer chemotherapy and radiotherapy.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ceresa, C | 1 |
| Avan, A | 2 |
| Giovannetti, E | 1 |
| Geldof, AA | 1 |
| Cavaletti, G | 1 |
| Peters, GJ | 1 |
1 other study available for amifostine anhydrous and Adrenal Cancer
| Article | Year |
|---|---|
Characterization of and protection from neurotoxicity induced by oxaliplatin, bortezomib and epothilone-B.
Topics: Adrenal Gland Neoplasms; Amifostine; Animals; Antineoplastic Agents; Apoptosis; Boronic Acids; Borte | 2014 |